Biopharmaceutical contract manufacturing Market

Biopharmaceutical contract manufacturing Market 2020 by Top Manufacturers, Growth, Trends, Size, Share, Analysis and Forecast to 2030

Over 35 CMOs / CDMOs in China claim to offer a variety of services related to development and manufacturing of a wide range of biotherapeutic products, claims Roots Analysis


Owing to benefits, such as reduced manufacturing costs, availability of cheap and skilled labor, and a supportive regulatory landscape, biopharmaceutical developers from across the globe, are increasingly outsourcing their manufacturing operations to China based CMOs. Further, in order to meet the growing demand for their services, Chinese CMOs are actively consolidating / expanding their capabilities through partnerships and / or dedicated expansion initiatives.  

The USD 2.6 billion (by 2030) financial opportunity within the China biopharmaceutical contract manufacturing market has been analyzed across the following segments:

Type of Product

  • API
  • FDF

Type of Expression System Used

  • Mammalian
  • Microbial
  • Others

Scale of Operation

  • Preclinical / Clinical
  • Commercial

Size of Manufacturer

  • Small
  • Mid-sized
  • Large / Very Large

Type of Biologic

  • Antibody
  • Vaccine
  • Others

The China Biopharmaceutical Contract Manufacturing Market, 2020-2030 report features the following companies, which we identified to be key players in this domain:

  • ChemPartner Biologics
  • JHL Biotech
  • JOINN Biologics
  • MabPlex
  • Mycenax Biotech
  • WuXi AppTec

Table of Contents

1. Preface

2. Executive Summary

3. Introduction

4. Case Study: Comparison of Small Molecules and Large Molecules

5. Competitive Landscape

6. Company Profiles

7. Partnerships

8. Recent Expansions

9. Clinical Trial Analysis

10. Regional Capability Analysis

11. Capacity Analysis

12. Big Pharma Biopharmaceutical Manufacturing Initiatives in China

13. Make Versus Buy Decision Making Framework

14. Market Sizing and Opportunity Analysis

15. COVID-19 Impact on China Biopharmaceutical CMO Market

16. SWOT Analysis

17. Future of the China Biopharmaceutical CMO Market

18. Interview Transcripts

19. APPENDIX 1: TABULATED DATA

20. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

For more information, please click on the following link:

https://www.rootsanalysis.com/reports/view_document/china-biopharmaceutical-contract-manufacturing/313.html    

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

Contact Information

Roots Analysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415

Gaurav.Chaudhary@rootsanalysis.com

Write a Comment